Hamilton Capital, LLC Eli Lilly & CO Transaction History

Hamilton Capital, LLC

$1.37 Billion
Q3 2024

A detailed history of Hamilton Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hamilton Capital, LLC holds 992 shares of LLY stock, worth $761,617. This represents 0.06% of its overall portfolio holdings.

Number of Shares

992

Previous 1,007 1.49%

Holding current value

$761,617

Previous $911,000 3.62%

% of portfolio

0.06%

Previous 0.07%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$772.14 - $960.02 $11,582 - $14,400	-15 Reduced 1.49%	992 $878,000
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $108,005 - $135,446	-149 Reduced 12.89%	1,007 $911,000
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $27,241 - $36,444	-46 Reduced 3.83%	1,156 $899,000
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $78,778 - $92,869	-150 Reduced 11.09%	1,202 $700,000
Q3 2023 Nov 15, 2023	BUY	$434.7 - $599.3 $18,692 - $25,769	43 Added 3.28%	1,352 $726,000
Q2 2023 Aug 03, 2023	SELL	$350.74 - $468.98 $20,342 - $27,200	-58 Reduced 4.24%	1,309 $613,000
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $538,632 - $632,597	-1,734 Reduced 55.92%	1,367 $469,000
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $655,640 - $763,952	2,039 Added 192.0%	3,101 $1.13 Million
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $15,120 - $17,231	51 Added 5.04%	1,062 $343,000
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $34,841 - $40,908	-125 Reduced 11.0%	1,011 $328,000
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $33,091 - $41,124	-141 Reduced 11.04%	1,136 $325,000
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $79,596 - $98,780	354 Added 38.35%	1,277 $353,000
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $204,536 - $251,711	923 New	923 $213,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Capital, LLC with notifications on news.

Account

Hamilton Capital, LLC Eli Lilly & CO Transaction History